Kimia Biosciences Limited (BOM:530313)
32.35
+0.55 (1.73%)
At close: Jun 18, 2026
Kimia Biosciences Revenue
In the fiscal year ending March 31, 2026, Kimia Biosciences had annual revenue of 1.15B INR, down -3.39%. Kimia Biosciences had revenue of 272.00M in the quarter ending March 31, 2026, a decrease of -28.88%.
Revenue
1.15B
Revenue Growth
-3.39%
P/S Ratio
1.32
Revenue / Employee
4.60M
Employees
250
Market Cap
1.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.15B | -40.37M | -3.39% |
| Mar 31, 2025 | 1.19B | 140.44M | 13.39% |
| Mar 31, 2024 | 1.05B | -236.40M | -18.39% |
| Mar 31, 2023 | 1.29B | 36.15M | 2.89% |
| Mar 31, 2022 | 1.25B | -78.13M | -5.89% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.72B |
| Panchsheel Organics | 1.07B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 902.48M |
| Tyche Industries | 628.56M |
| Vasundhara Rasayans | 357.23M |
| Accretion Nutraveda | 337.16M |
| Auro Laboratories | 307.40M |